Meiji Holdings

Basic Information

Stock Code
2269
Industry
Food Products
Category Detail
Food Manufacturing
Prefecture
Tokyo
Establishment Year
April 2009
Listing Year
April 2009
Official Website
https://www.meiji.com/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
Morinaga Milk, Rokko Butter, Yakult Honsha, Megmilk Snow Brand, Kikkoman, Aohata, Nissin Foods HD, JFLA Holdings

Overview

Meiji Holdings is a major food and pharmaceutical holding company established in 2009, leading in the dairy products and confectionery industries with a wide range of operations.

Current Situation

Meiji Holdings recorded consolidated sales of approximately 1.2527 trillion yen and operating profit of 102.7 billion yen for the fiscal year ended March 2020. Its core food business maintains a strong market position in both dairy products and confectionery manufacturing, while expanding in pharmaceuticals centered on Meiji Seika Pharma. The company focuses on improving production efficiency and product quality, stable raw material procurement, and enhancing customer recognition through brand unification. Amid fluctuating raw material prices and intensifying market competition, it pursues efficient management while actively addressing environmental burden reduction and developing health-oriented products. Moving forward, it aims for sustainable growth by expanding in the rapidly growing pharmaceuticals sector and health-related products, and developing sales channels both domestically and internationally.

Trivia

Interesting Facts

  • Meiji Holdings was formed historically from the merger of Meiji Seika and Meiji Milk.
  • The brand logo was unified to the red lowercase 'meiji' at the 2009 business integration.
  • Meiji is known as a sponsor for many professional sports in Japan.
  • Meiji's confections maintain long-term popularity with products like Kinoko no Yama and Take no Ko no Sato.
  • Meiji Seika Pharma is known for stable supply of pharmaceutical APIs.
  • Meiji is one of the pioneers in Japan's dairy industry.
  • The pharmaceuticals division is a key pillar of Meiji Holdings' diversification strategy.
  • Former Meiji Milk and Meiji Seika used different logos during their separate company eras.
  • Meiji serves as official sponsor for many Japanese high school soccer championships.
  • Known for rigorous quality control to meet Japan's food safety standards.
  • Many long-life products contribute to building corporate trust.
  • Meiji Holdings actively promotes employee stock ownership to foster corporate culture.
  • The group's pharmaceuticals business has history dating back to the Meiji Seika era.
  • Rare in Japan to have businesses in both food and pharmaceuticals.
  • Meiji refreshed its group slogan to 'Ideas for Health' in 2021.

Hidden Connections

  • Strengthened raw material procurement network through capital and business alliance with Mitsubishi Corporation Food Group.
  • Contributes to culture as long-term sponsor of drama programs on Nippon Television Network.
  • Deploys advertising strategies through long-term partnership with Yomiuri Shimbun Group.
  • Exclusive import and sales contract in Japan for former Cadbury chocolate products.
  • Official sponsor for Urawa Red Diamonds and Nagoya Grampus Eight.
  • Historical ties as advertising sponsor for Tokyo Dome and former Korakuen Stadium.
  • Achieves efficiency by sharing logistics and sales channels among multiple group companies.
  • Meiji Holdings supports education and social contribution through regional high school sports events.

Future Outlook

Growth Drivers

  • Increasing demand for health-oriented products in aging society
  • Advancement of technological innovations in functional foods and pharmaceuticals
  • Aggressive expansion into global food markets
  • Manufacturing and sales strategies emphasizing sustainability
  • Production efficiency and new product development promoted by digital technology
  • Deepening of region-rooted brand strategies
  • Enhanced response to diverse consumer needs
  • Strengthened adaptation to local needs in overseas markets
  • Implementation of food loss reduction and sustainable management
  • Leveraging synergies between pharmaceuticals and food sectors

Strategic Goals

  • Build sustainable product portfolio
  • Improve brand recognition domestically and internationally
  • Achieve significant CO2 emissions reduction targets
  • Double sales in pharmaceuticals sector
  • Reach 1.5 trillion yen in group-wide sales
  • Complete company-wide digitalization and automation
  • Strengthen coexistence with local communities and promote SDGs
  • Expand share in new health-related markets
  • Further diversify and stabilize raw material procurement
  • Form sustainable organization through improved employee satisfaction

Business Segments

Pharmaceutical Raw Materials Supply

Overview
Business stably supplying pharmaceutical raw materials for medical sites.
Competitiveness
Stable supply and development capabilities for high-quality raw materials
Customers
  • Domestic pharmaceutical companies
  • Overseas pharmaceutical manufacturers
  • Medical institutions
  • Research institutions
Products
  • Antibiotic APIs
  • Pharmaceutical intermediates
  • Drug substances

Food Raw Materials Provision

Overview
Supplies a wide range of raw materials for commercial food manufacturing.
Competitiveness
Diverse lineup of high-function raw material products
Customers
  • Confectionery manufacturers
  • Bakery producers
  • Beverage manufacturers
  • Commercial food traders
Products
  • Chocolate fillings
  • Dairy processed products
  • Functional materials

Logistics and Delivery Services

Overview
Provides safe logistics services for food and pharmaceuticals.
Competitiveness
Strengths in network and quality control
Customers
  • Retailers
  • Wholesalers
  • Restaurant chains
  • Pharmaceutical distribution
Products
  • Refrigerated and frozen logistics
  • Nationwide delivery services

Product Development Support

Overview
Technical support and planning proposals to promote product development.
Competitiveness
Collaboration leveraging group synergies
Customers
  • Subsidiary manufacturing divisions
  • External partners
  • R&D institutions
Products
  • Technical support services
  • Product development consulting

Competitive Advantage

Strengths

  • High brand recognition in dairy products and confectionery industries
  • Diversified business including pharmaceuticals
  • Stable raw materials procurement network
  • Strong technological development and product quality
  • Robust sales channels and distribution network
  • Synergy effects among group companies
  • Reliability backed by long history
  • Active new product development capabilities
  • Wide product lineup in domestic market
  • Efficiency and organizational improvements from business integration
  • Sustainability initiatives
  • Production system leveraging economies of scale
  • Foundation building for overseas expansion
  • Stable financial base
  • Advanced pharmaceutical technology and R&D capabilities

Competitive Advantages

  • Risk diversification through diversified operations covering both food and pharmaceuticals
  • Strong consumer loyalty to the Meiji brand
  • Specialized subsidiaries ensuring expertise in pharmaceuticals
  • Cost reductions and productivity improvements from integration
  • Market penetration through diverse sales channels
  • Solid manufacturing technology and quality control systems built over years
  • Global business foundation active in multiple markets
  • Customer base spanning young to elderly
  • New market creation through healthcare product development
  • Supply risk reduction via diversified raw material procurement
  • Practical application of new technologies through strong R&D investment
  • Swift decision-making across group companies under holding company structure
  • Robust food safety and quality assurance efforts
  • Market differentiation through expansion of environmentally friendly products
  • Implementation of advanced marketing strategies

Threats

  • Increasing risks from raw material price fluctuations
  • Intensifying domestic food market competition and price decline pressures
  • Market fluctuations from health trends and diversifying preferences
  • Shrinking domestic demand due to population decline
  • Regulatory and cultural differences in overseas markets
  • Impacts from social unrest such as new infectious diseases
  • Food safety issues and product recall risks
  • Profit fluctuations in overseas operations due to exchange rate changes
  • Impacts on production and logistics from natural disasters
  • Emergence of innovative products and technologies from competitors
  • Labor shortages and rising labor costs
  • Cost increases from strengthened environmental regulations

Innovations

2024: Established stable supply system for antibiotic APIs

Overview
Partnered with Sandoz to strengthen antibiotic API supply.
Impact
Completed foundation for stable growth in pharmaceuticals business.

2023: Launched new functional yogurt products

Overview
Expanded new yogurt line promoting gut environment improvement.
Impact
Gained high praise from health-conscious consumers.

2022: Developed bio-material-based products

Overview
Advanced development of functional foods using sustainable raw materials.
Impact
Successfully expanded environmentally considerate product line.

2021: Strengthened digital transformation

Overview
Introduced AI and IoT in manufacturing and logistics processes for efficiency.
Impact
Achieved significant productivity improvements and cost reductions.

2020: Launched new chocolate brand

Overview
Developed high-cacao brand catering to premium preferences.
Impact
Responded to market needs and strengthened brand image.

Sustainability

  • CO2 emissions reduction program in manufacturing processes
  • Expansion of renewable energy usage ratio
  • Ongoing reduction in plastic usage
  • Environmental conservation activities in collaboration with local communities
  • Distribution efficiency improvements to reduce food loss